- Filed
- Nov 7, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Nov 4, 2024 | 7.05M sh |
| Cash And Equivalents | Q3 2024 · Sep 30, 2024 | $127.39M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $35.78M |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $44.34M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $67.42M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $46.7M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $75.24M |
| Current Assets | Q3 2024 · Sep 30, 2024 | $156.77M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $60.86M |
| Total Assets | Q3 2024 · Sep 30, 2024 | $162.33M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $67.03M |
| Shares Diluted restated | Q3 2024 · Sep 30, 2023 | 4.51M sh |
| Shares Diluted restated | Q3 2024 · Sep 30, 2023 | 4.32M sh |
| Capex | Q3 2024 · Sep 30, 2023 | $327K |
| Operating Cash Flow | Q3 2024 · Sep 30, 2023 | −$9.71M |
| Stockholders Equity restated | Q3 2024 · Sep 30, 2023 | −$5.89M |
| Stockholders Equity restated | Q3 2024 · Jun 30, 2023 | $2.42M |
| Stockholders Equity restated | Q3 2024 · Mar 31, 2023 | $15.11M |
| Stockholders Equity restated | Q3 2024 · Dec 31, 2022 | −$14.44M |
| Eps Diluted restated | Q3 2024 · Sep 30, 2023 | −$2.02 |
| Eps Diluted restated | Q3 2024 · Sep 30, 2023 | −$4.56 |
| Eps Basic restated | Q3 2024 · Sep 30, 2023 | −$2.02 |
| Eps Basic restated | Q3 2024 · Sep 30, 2023 | −$4.56 |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $3.3M |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $10.13M |
| Rd Expense restated | Q3 2024 · Sep 30, 2023 | $10.39M |
| Rd Expense restated | Q3 2024 · Sep 30, 2023 | $28.75M |
| Net Income restated | Q3 2024 · Sep 30, 2023 | −$9.11M |
| Net Income restated | Q3 2024 · Sep 30, 2023 | −$19.72M |
| Net Income restated | Q3 2024 · Jun 30, 2023 | −$13.62M |
| Net Income restated | Q3 2024 · Mar 31, 2023 | $3.01M |
| Operating Income restated | Q3 2024 · Sep 30, 2023 | −$4.47M |
| Operating Income restated | Q3 2024 · Sep 30, 2023 | −$18.36M |